Iress (IRE) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
23 Dec, 2025Executive summary
Achieved record FY24 results ahead of guidance, driven by a multi-year transformation program, cost discipline, and focus on core businesses, resulting in a materially strengthened balance sheet.
Embedded new management disciplines, reset cost and asset base, and reinstated a final dividend of 10 cents per share after a pause during transformation.
Divested non-strategic assets, now focused on Trading & Global Market Data and Wealth Management, with Superannuation business sale to Apex Group expected to complete in Q2-25.
Significant uplift in customer sentiment, with Net Promoter Score up 25 points year-over-year.
Financial highlights
Adjusted EBITDA up 25.2% to $132.8m; margin expanded by over 500bps to 22.0% year-over-year.
Underlying EPS up 72.4% to 34.3 cps; NPATA increased 192% to $30.1m; statutory NPAT of $88.7m, up $226.2m from prior year loss.
Free cash flow up 192% to $30.1m; net debt reduced by over $200m to $111.6m; leverage ratio down to 1.0x from 2.5x.
Revenue down 3.4% to $604.6m due to asset sales, but up 4% on a continuing business basis.
Operating costs down 9% to $471.8m; headcount reduced by 15% to 1,530.
Outlook and guidance
FY25 guidance: NPATA $54m–$62m (up 80%–106% vs FY24), Adjusted EBITDA $127m–$135m.
Revenue growth expected at 4–5% for 2025, with cost growth at 3–5%, supporting further margin expansion.
Focus on growth in global wealth management, digital advice, data products, and cloud-based trading technologies.
Dividend payout ratio target set at 50–70% of NPATA going forward.
Latest events from Iress
- FY 2025 outperformed guidance, with margin expansion and strong FY 2026 growth outlook.IRE
H2 202524 Feb 2026 - Adjusted EBITDA up 52% and margin expansion drive upgraded guidance and dividend return.IRE
H1 20241 Feb 2026 - Strong FY24 results, board renewal, and decisive support for all resolutions.IRE
AGM 202528 Nov 2025 - EPS up 19.2%, revenue up 6.8%, leverage at 0.8x, interim dividend 11.0cps.IRE
H1 202523 Nov 2025